BDBM161076 US9682976, 30

SMILES Cn1nnn(-c2cc(Nc3ncc(F)c(NC4CC5CCC(C)(C)N5C(=O)C4)n3)c(F)cc2C2CC2)c1=O

InChI Key InChIKey=XNMBNYRPARHBJJ-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 161076   

TargetInterleukin-2(Human)
Rigel Pharmaceuticals

US Patent
LigandPNGBDBM161076(US9682976, 30)
Affinity DataEC50: >1.00E+4nMAssay Description:Primary T cell stimulation and IL2 ELISA: Human primary T cells (100,000 cells per well) were pre-incubated with or without test compound in Yssel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/14/2018
Entry Details
Go to US Patent